Elevated IGF-1 is expected and normal at appropriate doses, but it's worth confirming you're in a reasonable range
Purpose-built for physicians GLP-1 receptor agonists linked to lower mortality, respiratory failure in PAH Key takeaways: A link was found between GLP-1 receptor agonist use in PAH and significant decreases in mortality, respiratory failure, atrial fibrillation and ED visits
The FDA noted that Veronvy, a company that claims its products assist in weight loss and metabolism-boosting, said people on one of its products not only lost weight but also kept it off. In addition to a reduced-calorie diet and increased physical activity, Veronvy said its metabolic boost drops successfully helped people lose up to 52 pounds in three months during clinical trials and was approved by the Food and Drug Administration last year. The FDA said Veronvys products are intended to prevent, treat, or cure disease conditions and/or affect the structure or function of the body and categorized these supplements as unapproved drugs
Said he had been using it for a couple months and noticed his skin felt thicker and tighter around areas where he had some laxity
And what are the long-term consequences of PBMs holding the reins on these transformative therapies